(Q35216487)

7 August 2017

1 reference

title

Influence of immunosuppressive drugs on dendritic cells (English)

1 reference

7 August 2017

1 reference

2

Angus W Thomson

1 reference

7 August 2017

Masanori Abe

1

1 reference

7 August 2017

publication date

1 July 2003

1 reference

7 August 2017

published in

Transplant Immunology

1 reference

7 August 2017

volume

11

1 reference

7 August 2017

issue

3-4

1 reference

7 August 2017

page(s)

357-365

1 reference

Dendritic cells and the control of immunity

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Potential of tolerogenic dendritic cells for transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Dendritic cells, tolerance induction and transplant outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Dendritic cells, T cell tolerance and therapy of adverse immune reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

In vitro immunosuppressive effects of methotrexate and azathioprine on Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Studies on bredinin. I. Isolation, characterization and biological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

IMP dehydrogenase inhibitors as immunomodulators

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

The immunosuppressive mode of action of mizoribine

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Mycophenolate mofetil impairs the maturation and function of murine dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Low-dose immunosuppression by cyclosporine operating via antigen-presenting dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Blocking of acquisition and presentation of antigen by dendritic cells with cyclosporine. Studies with fluorescein isothiocyanate

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Differential Effects of Cytokines and Immunosuppressive Drugs on CD40, B7–1, and B7–2 Expression on Purified Epidermal Langerhans Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

The effect of cyclosporin A, FK506 and rapamycin on the murine contact sensitivity reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Dexamethasone and cyclosporin A affect the maturation of monocyte-derived dendritic cells differently

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

The effects of dexamethasone, cyclosporine, and vitamin D(3) on the activation of dendritic cells stimulated by haptens.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Bacterial lipopolysaccharide, TNF-alpha, and calcium ionophore under serum-free conditions promote rapid dendritic cell-like differentiation in CD14+ monocytes through distinct pathways that activate NK-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Cyclosporin A Inhibits the Antigen-Presenting Functions of Freshly Isolated Human Langerhans Cells In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Inhibitory effect of cyclosporin A on antigen and alloantigen presenting capacity of human epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Immunopharmacology of rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Inhibition of IL-12 signaling Stat4/IFN-gamma pathway by rapamycin is associated with impaired dendritic [correction of dendritc] cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Rapamycin impairs antigen uptake of human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Regulation of cytokine and cytokine receptor expression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Glucocorticoids down‐regulate dendritic cell function in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Differential effects of corticosteroids during different stages of dendritic cell maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

A novel mechanism of glucocorticoid-induced immune suppression: the inhibiton of T cell-mediated terminal maturation of a murine dendritic cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Direct effects of glucocorticosteroids on epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Reduction in murine Langerhans cell ATPase staining following topical but not systemic treatment with steroid and non-steroid immunosuppressants

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Modulation of Expression of Epidermal Langerhans Cell Properties Following in Situ Exposure to Glucocorticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Effect of glucocorticosteroids on epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Histochemical, immunohistochemical and ultrastructural studies on the action of glucocorticoids on epidermal Langerhans cells (ELC) of murine skin

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Inhibition by dexamethasone of Langerhans cell migration: influence of epidermal cytokine signals

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Glucocorticoid-mediated regulation of thymic dendritic cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Early differentiation of thymic dendritic cells in the absence of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Development of the airway intraepithelial dendritic cell network in the rat from class II major histocompatibility (Ia)-negative precursors: differential regulation of Ia expression at different levels of the respiratory tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Modulation of airway intraepithelial dendritic cells following exposure to steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Steroids inhibit uptake and/or processing but not presentation of antigen by airway dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Glucocorticoid-induced apoptosis of dendritic cells in the rat tracheal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Changes in dendritic cell subsets in the lymph nodes of rhesus macaques after application of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Glucocorticoids modulate the development of dendritic cells from blood precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Opposing effects of dehydroepiandrosterone and dexamethasone on the generation of monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Glucocorticoids increase the endocytic activity of human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Glucocorticoids hamper the ex vivo maturation of lung dendritic cells from their low autofluorescent precursors in the human bronchoalveolar lavage: decreases in allostimulatory capacity and expression of CD80 and CD86

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Inhibition of human dendritic cell functions by methylprednisolone.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Corticosteroids depress IFN-alpha-producing plasmacytoid dendritic cells in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Effect of 3 months' nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Epidermal cytokeratin and immunocyte responses during treatment of psoriasis with calcipotriol and betamethasone valerate

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

The effect of short-term corticosteroid incubation on the alloactivating and antigen-presenting capacity of human epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

A new antitumor antibiotic, spergualin: Isolation and antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

The immunosuppressant 15-deoxyspergualin [correction of 1,5-deoxyspergualin] reveals commonality between preT and preB cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Deoxyspergualin directly suppresses antibody formation in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Inhibitory effect of 1alpha,25-dihydroxyvitamin D3 on allogeneic lymphocyte stimulation and Langerhans cell maturation.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory t cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2803%2900050-9

7 January 2021

10.1016/S0966-3274(03)00050-9

Identifiers

DOI

1 reference

7 August 2017

1 reference